兢仁品牌怎么样 申请店铺

我要投票 兢仁在医疗保健行业中的票数:570 更新时间:2026-01-24
兢仁是哪个国家的品牌?「兢仁」是 河南兢仁医疗生物科技有限公司 旗下著名品牌。该品牌发源于河南郑州,由创始人王帅旗在2018-08-17期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力兢仁品牌出海!将品牌入驻外推网,定制兢仁品牌推广信息,可以显著提高兢仁产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

兢仁怎么样

河南兢仁医疗生物科技有限公司定位以前沿高新技术为核心,专业致力于医疗设备、中医药及云医疗的技术研发和解决方案服务商,总部位于郑州市。公司通过自主创新研发为各级医疗机构多科室提供精准康复医疗设备和创新治疗方案,涵盖消化内科、神经内科、烧伤科、心内科、骨科、眼科、康复科等多科室,普及高端精准康复医疗、掌握行业核心技术、提升服务品牌价值。

人才和创新是发展的源泉,应用和普惠是发展的目的。公司形成了“传承、创新、突破、引领”的发展理念和“以客户为中心、以市场为导向、以创新为标准”产品研发思路,与国内著名医学院校和科研机构开创性的建立战略性联创孵化平台、产学研开发机制,汇集了一批掌握国内外高新技术的医学、光学、机械、电子及计算机技术的高级人才,各类专业技术人员占公司总人数的85%以上。

以“为人类解决病痛传递健康而持续创新和探索”为使命,坚持“人无我有,人有我优、人优我先”的创新发展理念,积极于专业领域内“零到壹技术突破”的尝试和探索,掌握核心技术普惠大众。秉承“德仁治企”的核心价值观,志在树立行业新典范、定义行业新标准、引领行业新发展,塑造普惠众人的知名品牌,打造让业界和国人尊重的现代健康企业集团。

Henan Jingren Medical Biotechnology Co., Ltd. is a technology R & D and solution provider specializing in medical equipment, traditional Chinese medicine and cloud medical technology, with its headquarter in Zhengzhou. Through independent innovation and research and development, the company provides precision rehabilitation medical equipment and innovative treatment scheme for multiple departments of medical institutions at all levels, including digestive medicine, neurology, burn department, cardiology, orthopedics, ophthalmology, rehabilitation department and other departments, popularizes high-end precision rehabilitation medicine, grasps industry core technology, and improves service brand value. Talent and innovation are the source of development, and application and inclusion are the purpose of development. The company has formed the development concept of "inheritance, innovation, breakthrough and guidance" and the product R & D thought of "customer-oriented, market-oriented and innovation standard". It has established a strategic joint innovation incubation platform, production, research and development mechanism with famous medical colleges and scientific research institutions in China, and has gathered a group of medical, optical, mechanical and electrical technology master high and new technology at home and abroad All kinds of professional and technical personnel account for more than 85% of the total number of the company. With the mission of "continuous innovation and exploration to solve human disease and deliver health", the company adheres to the innovative development concept of "people without me, people with me, people with me first", actively tries and explores "zero to one technology breakthrough" in the professional field, and grasps the core technology to benefit the public. Adhering to the core values of "governing enterprises by virtue and benevolence", the company aims to establish a new model of the industry, define new standards of the industry, lead the new development of the industry, build a well-known brand of inclusive people, and build a modern healthy enterprise group that is respected by the industry and the Chinese people.

本文链接: https://brand.waitui.com/4a0e07250.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美股大型科技股盘前涨跌不一,Arm涨超2%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,Arm涨超2%,英伟达涨超1%,谷歌涨0.1%,微软涨0.06%;特斯拉跌0.17%,奈飞跌0.11%,亚马逊跌0.07%,苹果跌0.03%。

35分钟前

热门中概股美股盘前涨跌互现,阿里巴巴跌超1%

36氪获悉,热门中概股美股盘前涨跌互现,截至发稿,阿里巴巴、京东跌超1%,小鹏汽车跌近1%,网易跌0.48%,蔚来跌0.21%;百度涨超1%,拼多多涨0.75%,理想汽车涨0.42%,B站涨0.09%。

35分钟前

晶升股份:拟购买为准智能100%股份,交易作价8.57亿元

36氪获悉,晶升股份公告,公司拟通过发行股份及支付现金的方式购买本尚科技等10名交易对方持有的为准智能100%股份,同时募集配套资金。为准智能100%股份的交易作价为8.57亿元。本次交易构成关联交易和重大资产重组,但不构成重组上市。交易完成后,为准智能将成为上市公司控股子公司。

35分钟前

天合光能:将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”

36氪获悉,天合光能公告,公司拟缩减“年产35GW直拉单晶项目”的募集资金投资金额,不再实施二期15GW项目,并将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”。新项目预计2026年底建成并投入运营。公司表示,本次变更有利于提高募集资金使用效率,合理优化资源配置,巩固市场地位,不会对公司正常经营产生不利影响。该事项尚需提交公司股东会和债券持有人会议审议通过后方可实施。

35分钟前

宝洁第二财季净销售额222亿美元,同比增长1%

当地时间1月22日,宝洁公司发布2026财年第二季度(2025年10-12月)财报。财报显示,第二财季净销售额为222亿美元,同比增长1%;摊薄后每股净收益为1.78美元,同比下降5%。该公司维持2026财年总销售额同比增长1%至5%的指引区间,将2026财年摊薄后每股净收益增长指引从原先的3%-9%调整至1%-6%。(界面)

35分钟前

本页详细列出关于兢仁的品牌信息,含品牌所属公司介绍,兢仁所处行业的品牌地位及优势。
咨询